CASE STUDY: AUTOLOGOUS STEM CELL TREATMENT VIA PERIPHERAL BLOOD HARVEST IN A 70 YEAR OLD FEMALE FOR FACIAL

REJUVENATION AND REGENERATIVE PURPOSE This case study is of a 70 year old female who underwent a peripheral infusion of autologous stem cells on 23rd May 2013. 250ml of her peripheral blood was taken via venepuncture with a 16 gauge catheter which was then transported to the labs of Autologous Stem Cell Technology for the autologous conversion of stem cells. On 27th May 2013, 1.5 x 108 of her converted stem cells bearing the following CD markers were infused through an IV infusion in her forearm over the course of 2 hours.

CD Markers: CD 38, CD 90 (haematopoietic/lymphoid stem cells) CD11b,CD31,CD44,CD105 (mesenchymal stem cells) CD7,CD59,CD84 (haematopoietic stem cells) CD49d (Neuronl Stem Cells) CD45 (haematopoietic progenitors) CD9,CD30 CD7 (pluripotent stem cells)

The facial rejuvenation was performed simultaneously with her intravenous stem cells infusion. The stem cells were injected intra-dermally to all areas of her face in a linear retro-grade technique. Several layers of stem cell fillings were performed to the naso-labils, peri-oral, peri-ocular, forehead glabellar areas. Approximately 20ml 40ml in total was used for the full face rejuvenation procedure. Patient was discharged well. Immediately post procedure, patient noted minimal bruising and swelling for 24 hours post procedure.

Patient was followed up over an interval of 6 weeks and noted the following effects: Improved skin laxity Improved texture Decreased pigmentation Decreased naso-labial folds Decreased glabellar lines Improved peri-ocular lines Neo-colagen formation Reduced pore size Diminished rhytids

The picture below is taken immediately post treatment:

The picture below is taken 1 week post stem cell facial rejuvenation:

The picture below is taken 6 weeks post stem cell facial rejuvenation:

This patient will be followed up with 3 month intervals to assess continuing clinical outcomes post transplant.

Further updates to this case study will be made once more results become available.

Dr Kellie Scheuner B.Biomed.Sc (Hons) MB BS (Hons) Attending Medical Practitioner